Login / Signup

An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist.

Amy McGoldrickHelen ByrneCathal A Cadogan
Published in: International journal of clinical pharmacy (2023)
The findings highlight a lack of detailed reporting of antidepressant tapering methods in published trials to date. This needs to be addressed as poor reporting could hinder replication and adaptation of existing interventions, as well as the potential for successful translation of effective tapering interventions into clinical practice.
Keyphrases
  • adverse drug
  • major depressive disorder
  • clinical practice
  • physical activity
  • emergency department
  • randomized controlled trial
  • systematic review
  • bipolar disorder